Bolstering community approach in Guinea’s Ebola fight

A few days after he referred a patient from his clinic to the regional hospital, Emmanuel Goepogui, a private practitioner in N’Zerekore prefecture in south-eastern Guinea, received a visit by a community disease surveillance team. “They came to inform me that my patient had tested positive for Ebola and that I was a direct contact,” he says.

Genome sequencing in Ebola response

Studies show that the Ebola virus can persist in bodily fluids – such as semen and breast milk – of survivors for months. The recent resurgence of Ebola in Guinea and the Democratic Republic of the Congo has been linked to bodily fluids of survivors.

New Ebola outbreak declared in Guinea

Health authorities in Guinea today declared an outbreak of Ebola in the rural community of Gouéké in N’Zerekore prefecture after three Ebola cases were confirmed by the national laboratory, marking the first time the disease has been reported in the country since an outbreak ended in 2016.

Overcoming COVID-19 at 99 years-old in Guinea

When Bagama Guehara walked out of Donka Hospital in Guinea’s capital, Conakry, on 7 July this year, leaning on a walking stick for support, she was met with a rapturous applause from the medical staff and fellow patients.

Ebola vaccines for Guinea and the world

More than 11 000 people in Guinea participated in a WHO-led trial to develop the world’s first vaccine against Ebola virus disease. The ground-breaking trial, which ended in January 2016, resulted in a vaccine that is highly protective against the deadly virus. The Director-General of WHO, Dr Margaret Chan and the WHO Regional Director for Africa, Dr Matshidiso Moeti visited some of the communities who participated in the vaccine trial in the city of Conakry.